Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored vs Empiric Therapy for H. pylori
NCT02935010Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2017
- Primary completion
- Mar 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, bismuth subcitrate, amoxicillin, clarithromycin, metronidazole in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Started Feb 2017; status: completed.
02
Drugs
esomeprazolebismuth subcitrateamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02935010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935010.